M, J., ZQ, J., JH, Q., HX, Q., KW, J., HX, Y., . . . SQ, L. Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma. Dove Medical Press.
Chicago Style (17th ed.) CitationM, Jin, et al. Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma. Dove Medical Press.
MLA (9th ed.) CitationM, Jin, et al. Efficacy and Safety of Lenvatinib Plus Programmed Death-1 Inhibitors with or Without Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma. Dove Medical Press.
Warning: These citations may not always be 100% accurate.